Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Kukreja N, Onuma Y, Garcia-Garcia HM et al. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc. Interv. 2 (6), 534–541 (2009).
  MedlineGoogle Scholar
• 2 Leibundgut G, Nietlispach F, Pittl U, Brunner-La Rocca H, Kaiser CA, Pfisterer ME. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina-comparison of the effects of drug-eluting versus bare-metal stents. Am. Heart J. 158 (2), 271–276 (2009).
  Medline CASGoogle Scholar
• 3 Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis.in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 356 (10), 1020–1029 (2007).
  Medline CASGoogle Scholar
• 4 Park D-W, Yun S-C, Lee J-Y et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 120 (20), 1987–1995 (2009).
  Medline CASGoogle Scholar
• 5 Cook S, Ladich E, Nakazawa G et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 120 (5), 391–399 (2009).
  MedlineGoogle Scholar
• 6 Palmerini T, Coller BS, Cervi V et al. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J. Am. Coll. Cardiol. 44 (8), 1570–1577 (2004).
  Medline CASGoogle Scholar
• 7 Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62 (5), 707–714 (1977).
  Medline CASGoogle Scholar
• 8 Nissen SE, Tsunoda T, Tuzcu EM et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (17), 2292–2300 (2003).
  Medline CASGoogle Scholar
• 9 Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101 (26), 9774–9779 (2004).
  Medline CASGoogle Scholar
• 10 Tardif J-C, Grégoire J, L'Allier PL et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297 (15), 1675–1682 (2007).
  MedlineGoogle Scholar
• 11 Murphy AJ, Woollard KJ, Hoang A et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28 (11), 2071–2077 (2008).
  Medline CASGoogle Scholar
• 12 Westerterp M, Gourion-Arsiquaud S, Murphy AJ et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 11 (2), 195–206 (2012).
  Medline CASGoogle Scholar
• 13 Leuschner F, Rauch PJ, Ueno T et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209 (1), 123–137 (2012).
  Medline CASGoogle Scholar
• 14 Kanbay M, Solak Y, Unal HU et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol. 46 (8), 1619–1625 (2014).•• This was the first study demonstrating monocyte to HDL ratio as a prognostic marker of cardiovascular events in chronic kidney disease.
  Medline CASGoogle Scholar
• 15 Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol. 60 (16), 1581–1598 (2012).
  MedlineGoogle Scholar
• 16 Cutlip DE, Windecker S, Mehran R et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (17), 2344–2351 (2007).
  MedlineGoogle Scholar
• 17 Cutlip DE, Baim DS, Ho KK et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (15), 1967–1971 (2001).
  Medline CASGoogle Scholar
• 18 Hoshida S, Nishino M, Takeda T, Tanouchi J, Yamada Y, Hori M. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins. Atherosclerosis 173 (2), 285–290 (2004).
  Medline CASGoogle Scholar
• 19 Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc. Med. 18 (6), 228–232 (2008).
  Medline CASGoogle Scholar
• 20 Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7 (2), 77–86 (2010).• This review impacts on the importance of monocytes in atherosclerosis.
  MedlineGoogle Scholar
• 21 Qiao JH, Tripathi J, Mishra NK et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150 (5), 1687–1699 (1997).
  Medline CASGoogle Scholar
• 22 Van der Laan AM, Hirsch A, Robbers LFHJ et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am. Heart J. 163 (1), 57.e2–65.e2 (2012).• This study reported the association of the proinflammatory monocyte response with myocardial injury and impaired outcomes in ST-segment elevation myocardial infarction.
  Google Scholar
• 23 Müller K, Aichele S, Herkommer M et al. Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease. Atherosclerosis 213 (1), 256–262 (2010).
  Medline CASGoogle Scholar
• 24 Swirski FK, Libby P, Aikawa E et al. Ly–6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117 (1), 195–205 (2007).
  Medline CASGoogle Scholar
• 25 Ziegler-Heitbrock L, Ancuta P, Crowe S et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116 (16), e74–e80 (2010).
  Medline CASGoogle Scholar
• 26 Kontush A, Chapman MJ. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 3 (3), 144–153 (2006).• This article emphasizes on the HDL particle in atherosclerosis.
  Medline CASGoogle Scholar
• 27 Boisvert WA, Black AS, Curtiss LK. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages. Arterioscler. Thromb. Vasc. Biol. 19 (3), 525–530 (1999).
  Medline CASGoogle Scholar
• 28 D'Ascenzo F, Bollati M, Clementi F et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int. J. Cardiol. 167 (2), 575–584 (2013).
  MedlineGoogle Scholar